Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study

By Hill Simon   Elhilali Mostafa   Millard Richard J   Dwyer Peter L   Lheritier Karine   Kawakami Fernando T.   Steel Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2697-2704

Informa Healthcare

Access to resources Recommend Favorite

An open‐label extension long‐term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 2, 2018-02 ,pp. : 84-94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

By Montgomery Stuart   Emir Birol   Haswell Hannah   Prieto Rita  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1223-1230

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)

By  

Respiration, Vol. 94, Iss. 5, 2017-09 ,pp. : 408-415

Karger

Access to resources Recommend Favorite